USPTO CRISPR Patent Decision Keeps Status Quo
Many scientific breakthroughs are being made using CRISPR gene editing technology, but there is uncertainty regarding ownership of the intellectual property
Synthetic DNA is changing the way research is performed, allowing scientists to focus on performing their experiments and accelerating their discoveries.
Twist Bioscience’s expansion into its new 12,000-square-foot South San Francisco property more than doubles our current production space, providing a launch pad for the next phase of growth and development.
© 2013 - 2017 Twist Bioscience. All rights reserved.